scholarly journals Visual Loss Treated with Osimertinib: A Case Report

Author(s):  
Dimitrios Drekolias ◽  
Scott D. Walter ◽  
Todd Alekshun
Keyword(s):  
2000 ◽  
Vol 23 (2) ◽  
pp. 89-94 ◽  
Author(s):  
Holger Allroggen ◽  
Richard J. Abbott ◽  
Kim Bibby

Author(s):  
Seda Aybüke SARI ◽  
Ayla UZUN ÇİÇEK ◽  
Özge DOMBAYCI

Cases Journal ◽  
2008 ◽  
Vol 1 (1) ◽  
pp. 322 ◽  
Author(s):  
Shailesh K Gupta ◽  
Vikram S Brar ◽  
Ravi Keshavamurthy ◽  
Kakarla V Chalam

1995 ◽  
Vol 35 ◽  
pp. S216
Author(s):  
G. Caputo ◽  
F. Becquet ◽  
J.E. Guez ◽  
D. Chauvaud ◽  
Y. Pouliquen

2017 ◽  
Vol 8 (1) ◽  
pp. 21-25 ◽  
Author(s):  
Sylvia Nghiem-Buffet ◽  
Salomon Yves Cohen ◽  
Audrey Giocanti-Auregan

Background: To report the use of En-face optical coherence tomography (OCT) in a patient treated with docetaxel and tamoxifen for breast cancer for the detection of macular edema (ME) without evidence of leakage on fluorescein angiography (FA). Case Presentation: A 52-year-old woman treated for breast cancer presented with bilateral visual loss for 2 months. FA showed no significant leakage while spectral-domain OCT scans of both eyes showed foveolar and parafoveolar cystic spaces in a moderately thickened macula. En-face OCT segmented at the inner retina showed the petaloid arrangement of cystic cavities, comparable to a cystoid ME. Conclusions: The combined use of tamoxifen could have potentiated the toxic effect of docetaxel on the macula. En-face OCT images may reveal a petaloid aspect of the macula due to cysts in the inner retina segmentation, when FA shows no leakage.


Sign in / Sign up

Export Citation Format

Share Document